So, 21 patients still alive (half of 42)! That’s impressive.
Launch looks to take place later in the year in the UK, Germany and Belgium. Makes sense that’s were the treating hospitals were located.
Targeting circa $100-$150 million in annual sales in five years. That’s impressive as well. And remember this is only for CE Mark. Does not take into account if they get full FDA approval for US, China and Japan.
This is all very good news. And yet the market keeps ignoring and selling???
OSL Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)